Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970107_sep96_decls58_0003.txt
Subject: JUSTIFICATION APPROVAL FOR CIPROFLOXACIN FOR ODS 18 JAN 91
Unit: OTSG
Parent Organization: HSC
Box ID: BX003201
Folder Title: APPROVAL FOR ANTIBIOTIC CIPROFLOXACIN FOR DESERT SHIELD
Document Number: 1001
Folder Seq #: 6
Antibiotic Ciprofloxacin
DAMD17-91-C-1032
JUSTIFICATION AND APPROVAL
FOR OTHER THAN FULL AND OPEN COMPETITION
1. Contractina Aaency - U.S. Army Medical Research and
Development Command, Fort Detrick, Frederick, MD 21702-5012.
2. Descri-otion of Action - The acquisition is for a new firm-
fixed-price type contract utilizing OMA funds. A letter contract
was awarded 06 December 1990. Definitization of the letter
contract was completed 04 January 1991.
3. Description of Supplies/Services - Thirty million 500 mg.
tablets of the antibiotic ciprofloxacin will be acquired, with the
option to purchase an additional thirty million tablets. The
total contract value, including the option, is $90 million. The
price per tablet is $1.50.
4. Authority Cited - This action is authorized under 10 U.S.C.
2304(c)(2), unusual and compelling urgency (as implemented by FAR
6.302-2).
5. Reason for Authority Cited -
a. To date, diarrhea has been the most common medical problem
encountered during Operation Desert Shield. Between 2-5 percent
of troops in the Operation visit health care facilities every week
for diarrhea; however, only 20 percent of persons are presenting
themselves for treatment, thus approximately 20,000 cases per week
are occurring. The problem will become worse as more new forces
are deployed, and the present cool weather subsides. A common
form of diarrhea, in the geographic area, is resistant to all
commonly used antibiotics except ciprofloxacin. The required
delivery schedule of tablets for treatment is as follows:
5,000,000 11 Dec 90
5,000,000 18 Dec 90
5,000,000 21 Dec 90
5,000,000 03 Jan 91
5,000,000 15 Jan 91
5,000,000 22 Jan 91
b. The contractor is Miles, Inc., West Haven, CT, the only
pharmaceutical firm in the U.S. licensed by the Food and Drug
Administration (FDA) to produce ciprofloxacin.
6. Efforts to Obtain Competition
a. There are no other FDA licensed producers of
ciprofloxacin; accordingly, no effort was made to solicit offers
from other sources. Deployment of vaccines and drugs not licensed
2
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 6 f:/Week-36/BX003201/APPROVAL FOR ANTIBIOTIC CIPROFLOXACIN FOR DESERT SHIELD/justification approval for ciprofloxacin for od:01029715474559
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = APPROVAL FOR ANTIBIOTIC CIPROFLOXACIN FOR DESERT SHIELD
Folder Seq # = 6
Subject = JUSTIFICATION APPROVAL FOR CIPROFLOXACIN FOR OD
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997